Liver Involvement in Patients with Rare MBOAT7 Variants and Intellectual Disability: A Case Report and Literature Review

Genes (Basel). 2023 Aug 16;14(8):1633. doi: 10.3390/genes14081633.

Abstract

The membrane-bound O-acyltransferase domain-containing 7 (MBOAT7) protein is an acyltransferase catalyzing arachidonic acid incorporation into lysophosphatidylinositol. Patients with rare, biallelic loss-of-function variants of the MBOAT7 gene display intellectual disability with neurodevelopmental defects. The rs641738 inherited variant associated with reduced hepatic MBOAT7 expression has been linked to steatotic liver disease susceptibility. However, the impact of biallelic loss-of-function MBOAT7 variants on liver disease is not known. We report on a 2-year-old girl with MBOAT7-related intellectual disability and steatotic liver disease, confirming that MBOAT7 loss-of-function predisposes to liver disease.

Keywords: LPIAT1; fatty liver disease; intellectual disability; membrane-bound O-acyltransferase domain-containing 7 (MBOAT7); steatotic liver disease.

Publication types

  • Review
  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acyltransferases / genetics
  • Arachidonic Acid
  • Child, Preschool
  • Female
  • Humans
  • Intellectual Disability* / genetics
  • Membrane Proteins
  • Patients

Substances

  • Acyltransferases
  • Arachidonic Acid
  • MBOAT7 protein, human
  • Membrane Proteins

Grants and funding

Italian Ministry of Health (Ministero della Salute), Ricerca Finalizzata 2016, RF-2016-02364358 (“Impact of whole exome sequencing on the clinical management of patients with advanced nonalcoholic fatty liver and cryptogenic liver disease”), Ricerca Finalizzata 2021, RF-2021-12373889, Italian Ministry of Health, Ricerca Finalizzata PNRR 2022 “RATIONAL: Risk strAtificaTIon of Nonalcoholic fAtty Liver” PNRR-MAD-2022-12375656 (LV); Italian Ministry of Health (Ministero della Salute), Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Ricerca Corrente (LV); Italian Ministry of Health (Ministero della Salute, Direzione Generale della Ricerca e dell’Innovazione in Sanità), Fondazione IRCCS Ca’ Granda, 5x1000 2020 funds (RC5100020G) (LV); and University of Milan (Bando interno UNIMI PSR2021_DIP_009_09 Linea 2 anno 2021) (LV).